Patrick SHANNON,Roberto Carlos BRAVO GONZÁLEZ,Jean DUCASSOU
申请号：
US15771484
公开号：
US20200009098A1
申请日:
2016.10.31
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Provided herein are fixed-dose combination formulations of a pharmaceutically effective amount of eflornithine together with a pharmaceutically effective amount of sulindac. Also provided are methods of use and of methods of manufacture of these formulations.
